1. 133 Development of novel cellular therapeutics for metastatic and primary CNS malignancies. (9th November 2020) Authors: Rennert, Paul; Birt, Alyssa; Su, Lihe; Wu, Lan; Dufort, Fay; Lobb, Roy; Ambrose, Christine; Rennert, Paul Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 133 Development of novel cellular therapeutics for metastatic and primary CNS malignancies. (9th November 2020) Authors: Rennert, Paul; Birt, Alyssa; Su, Lihe; Wu, Lan; Dufort, Fay; Lobb, Roy; Ambrose, Christine; Rennert, Paul Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CAR-T Engager proteins optimize anti-CD19 CAR-T cell therapies for lymphoma. (31st December 2022) Authors: Su, Lihe; Wu, Lan; Lobb, Roy R.; Rennert, Paul D.; Ambrose, Christine Journal: Oncoimmunology Issue: Volume 11:Number 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CAR-T Engager proteins optimize anti-CD19 CAR-T cell therapies for lymphoma. (31st December 2022) Authors: Su, Lihe; Wu, Lan; Lobb, Roy R.; Rennert, Paul D.; Ambrose, Christine Journal: Oncoimmunology Issue: Volume 11:Number 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗